News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
50 % of men will have a rising PSA after prostatectomy for Prostate Cancer – ASCO
Photo: Depositphotos
Apr 2, 2025, 07:35

50 % of men will have a rising PSA after prostatectomy for Prostate Cancer – ASCO

ASCO shared a post on X:

“CYMI: 1/2 of men who’ve undergone prostatectomy for Prostate Cancer will have a rising PSA, which means physicians must locate the biochemical recurrence to tailor treatment.

Nicholas Zaorsky, Amar Kishan and Daniel E Spratt discuss for ASCO DailyNews.”

prostatectomy

Further Reading: 

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

Immunotherapy for Prostate Cancer

Prostate Cancer: What patients should know about

ASCO cancer OncoDaily Oncology prostate cancer prostatectomy PSA test
Special Coverage
Voices
Aug 25, 2025, 14:44
Miriam Mutebi: So, Here’s Why Basic and Translational Research Is Important
Voices
Aug 25, 2025, 14:42
Gustavo Viani: A Game Changer in Cervical Cancer RT?
Insight
Aug 25, 2025, 14:34
Philipp Ivanyi Highlights Need for Reconsideration in Cancer Treatment Landscape
Voices
Aug 25, 2025, 14:32
Douglas Flora: America Is Abandoning One of the Greatest Medical Breakthroughs
Insight
Aug 25, 2025, 14:21
Anirban Maitra Highlights New Paper on Therapeutic Targets for Pancreatic Cancer
OncoDaily Pulse
Aug 25, 2025, 14:16
Padraic O’Malley: Meet the Experts of VIRO 2025
Insight
Aug 25, 2025, 14:15
Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld
Voices
Aug 25, 2025, 13:49
Mario I Fernandez: Joining LATAM Bladder Cancer Experts at the IBCG in Houston
Voices
Aug 25, 2025, 13:34
Gevorg Tamamyan: Hemostasis Today - A New Era in Hemostasis and Thrombosis Reporting
Career Updates
Aug 25, 2025, 13:16
Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
FDA Approvals
Aug 25, 2025, 13:00
FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC
Science
Aug 25, 2025, 12:37
Stephen V Liu: Chronic Kidney Disease Risk After Cisplatin Chemotherapy